ORBACTIV

This brand name is authorized in Austria, Estonia, United States.

Active ingredients

The drug ORBACTIV contains one active pharmaceutical ingredient (API):

1	Oritavancin UNII PUG62FRZ2E - ORITAVANCIN
	Oritavancin is used for the treatment of patients with acute bacterial skin and skin structure infections (ABSSSI).
	Read more about Oritavancin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ORBACTIV Powder for solution for injection	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01XA05		J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01X Other antibacterials → J01XA Glycopeptide antibacterials
Discover more medicines within J01XA05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1680960
US	FDA, National Drug Code	65293-015, 70842-140